医药玻璃容器市场规模、份额及成长分析（按材料、产品、药物类型及地区划分）－2026-2033年产业预测

预计到 2024 年，医药玻璃包装市场规模将达到 219.4 亿美元，到 2025 年将达到 240.5 亿美元，到 2033 年将达到 500.7 亿美元，在预测期（2026-2033 年）内，复合年增长率为 9.6%。

医药玻璃包装市场的成长主要得益于医药产业的扩张以及消费者对玻璃材质的偏好，因为玻璃具有许多优良特性。这一趋势的动力来自玻璃回收利用力度的加大，尤其是在已开发国家。医药玻璃容器对于储存和包装各种物质（包括强酸和强碱）至关重要。技术创新发挥关键作用，物流公司不断创新以提升其市场地位。此外，产业向永续包装手法的转变也反映了消费者对环保产品日益增长的需求。玻璃瓶因其100%可回收性和与内容物无反应的特性而成为一种永续的选择。回收技术的进步有望降低成本，进一步推动玻璃在循环经济中的应用，同时个人化包装也越来越受欢迎。

医药玻璃包装市场成长要素

生物製药（例如单株抗体和疫苗）日益普及，是推动全球医药玻璃包装市场成长的主要动力。这些生物製药需要符合高安全性和无菌标准的包装解决方案，以维持其疗效。由于玻璃具有惰性、耐用性和能够保持敏感药物完整性等优点，因此通常被选为首选材料，这也显着增加了医疗产业对管瓶和注射器的需求。因此，不断扩张的生物製药产业正在推动对先进玻璃包装解决方案的强劲需求，从而促进市场扩张。

限制医药玻璃包装市场发展的因素

製药企业日益倾向于使用塑胶和金属等替代材料进行包装，这对製药玻璃包装市场构成了重大挑战。这些替代材料通常更具成本效益、重量更轻、柔软性，因此对寻求经济实惠且用途广泛的製药公司极具吸引力。随着企业在包装选择上优先考虑经济实惠且适应性强的解决方案，对传统玻璃包装的需求可能会受到限制，进而影响製药业玻璃包装市场的整体成长。

医药玻璃包装市场趋势

目前，医药玻璃包装市场正呈现显着上升趋势，这主要得益于生物製药包装需求的激增。疫苗和单株抗体等生物製药的研发和广泛应用，推动了对专用玻璃包装解决方案的需求。管瓶和注射器因其能提供安全无菌的环境，确保这些敏感药物的稳定性和有效性，而日益受到青睐。这种转变不仅凸显了先进包装技术的必要性，也反映了整个製药业对保护药物完整性和提升病人安全的重视。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析和影响

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 技术进步
• 监管环境
• 案例研究
• 专利分析
• 贸易分析

医药玻璃容器市场：依材质分類的市场规模及复合年增长率（2026-2033）

• 一型
• II 型
• III型

医药玻璃容器市场：依产品分類的市场规模及复合年增长率（2026-2033）

• 管瓶
  • 管瓶
  • 大号管瓶
• 瓶子
• 墨水匣和注射器
• 安瓿

医药玻璃容器市场：依药物类型分類的市场规模及复合年增长率（2026-2033）

• 学名药
• 品牌药
• 生物製剂

医药玻璃容器市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 英国
  • 德国
  • 西班牙
  • 法国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2021-2023年营收年比比较

主要企业简介

• Gerresheimer AG（Germany）
• Corning Incorporated（USA）
• Nipro Corporation（Japan）
• SGD SA（SGD Pharma）（France）
• Stolzle-Oberglas GmbH（CAG Holding GmbH）（Austria）
• Bormioli Pharma SpA（Italy）
• West Pharmaceutical Services Inc.（USA）
• Schott AG（Germany）
• Shandong Pharmaceutical Glass Co. Ltd.（China）
• Beatson Clark（United Kingdom）
• Arab Pharmaceutical Glass Co.（Egypt）
• Piramal Glass Private Limited（Piramal Group）（India）
• Sisecam Group（Turkey）
• Verallia（France）
• Shandong Yaowei Pharmaceutical Glass Co., Ltd.（China）
• Zhejiang Huachuang Pharmaceutical Glass Co., Ltd.（China）
• Changzhou Huaxing Pharmaceutical Glass Co., Ltd.（China）
• Jiangsu Huaxing Pharmaceutical Glass Co., Ltd.（China）
• Jiangsu Kaidi Pharmaceutical Glass Co., Ltd.（China）
• Jiangsu Yikang Pharmaceutical Glass Co., Ltd.（China）

结论与建议

Pharmaceutical Glass Packaging Market size was valued at USD 21.94 Billion in 2024 and is poised to grow from USD 24.05 Billion in 2025 to USD 50.07 Billion by 2033, growing at a CAGR of 9.6% during the forecast period (2026-2033).

The growth of the pharmaceutical glass packaging market is driven by the expansion of the pharmaceutical sector and consumer preference for glass due to its beneficial properties. Increasing glass recycling efforts, particularly in developed nations, complement this trend. Pharmaceutical glass containers are essential for storing and packaging various materials, including strong acids and alkalis. Technological advancements play a pivotal role, with logistics companies innovating to enhance market positioning. Additionally, the industry's shift toward sustainable packaging practices reflects growing consumer demand for eco-friendly options. Glass jars stand out as a sustainable choice, being 100% recyclable and non-reactive with contents. Enhanced recycling technologies are expected to lower costs, further encouraging the adoption of glass in the circular economy, while personalized packaging continues to rise in popularity.

Top-down and bottom-up approaches were used to estimate and validate the size of the Pharmaceutical Glass Packaging market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Pharmaceutical Glass Packaging Market Segments Analysis

Global Pharmaceutical Glass Packaging Market is segmented by Material, Product, Drug Type and Region. Based on Material, the market is segmented into Type I, Type II, Type, III. Based on Product, the market is segmented into Vials, Bottles, Cartridges and Syringes, Ampoules. Based on Drug Type, the market is segmented into Generic, Branded, Biologic. Based on Region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Pharmaceutical Glass Packaging Market

The increasing prevalence of biologics, such as monoclonal antibodies and vaccines, serves as a key driver for the growth of the global pharmaceutical glass packaging market. These biologics require packaging solutions that meet high standards of safety and sterility to maintain their efficacy. This requirement significantly elevates the demand for glass vials and syringes in the healthcare industry, as glass is often preferred for its inert properties, durability, and ability to preserve the integrity of sensitive medications. Consequently, the expanding biopharmaceutical sector is fostering a robust need for advanced glass packaging solutions, thereby propelling market expansion.

Restraints in the Pharmaceutical Glass Packaging Market

The increasing preference for alternative materials like plastic and metal in pharmaceutical packaging presents a significant challenge to the pharmaceutical glass packaging market. These alternatives are often more cost-effective, lighter in weight, and offer greater flexibility, making them appealing to pharmaceutical manufacturers looking for economical and versatile options. As companies prioritize budget-friendly solutions and adaptability in their packaging choices, the demand for traditional glass packaging may face constraints, potentially impacting the overall growth of the glass packaging sector within the pharmaceutical industry.

Market Trends of the Pharmaceutical Glass Packaging Market

The Pharmaceutical Glass Packaging market is currently experiencing a significant upward trend, primarily driven by the surging demand for biologic drug packaging. With the rise in the development and utilization of biologics such as vaccines and monoclonal antibodies, there is an escalated need for specialized glass packaging solutions. Glass vials and syringes are increasingly favored due to their ability to provide a safe and sterile environment, ensuring the stability and efficacy of these sensitive pharmaceuticals. This shift not only emphasizes the necessity for advanced packaging technologies but also reflects the broader industry focus on safeguarding drug integrity and enhancing patient safety in the pharmaceutical sector.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Case Studies
• Patent Analysis
• Trade Analysis

Pharmaceutical Glass Packaging Market Market Size by Material & CAGR (2026-2033)

• Market Overview
• Type I
• Type II
• Type III

Pharmaceutical Glass Packaging Market Market Size by Product & CAGR (2026-2033)

• Market Overview
• Vials
  • Small Vials
  • Large Vials
• Bottles
• Cartridges and Syringes
• Ampoules

Pharmaceutical Glass Packaging Market Market Size by Drug Type & CAGR (2026-2033)

• Market Overview
• Generic
• Branded
• Biologic

Pharmaceutical Glass Packaging Market Size & CAGR (2026-2033)

• North America (Material, Product, Drug Type)
  • US
  • Canada
• Europe (Material, Product, Drug Type)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific (Material, Product, Drug Type)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America (Material, Product, Drug Type)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Material, Product, Drug Type)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Gerresheimer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corning Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SGD SA (SGD Pharma) (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stolzle-Oberglas GmbH (CAG Holding GmbH) (Austria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bormioli Pharma S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• West Pharmaceutical Services Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Schott AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shandong Pharmaceutical Glass Co. Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beatson Clark (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arab Pharmaceutical Glass Co. (Egypt)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Piramal Glass Private Limited (Piramal Group) (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sisecam Group (Turkey)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Verallia (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shandong Yaowei Pharmaceutical Glass Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zhejiang Huachuang Pharmaceutical Glass Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Changzhou Huaxing Pharmaceutical Glass Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jiangsu Huaxing Pharmaceutical Glass Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jiangsu Kaidi Pharmaceutical Glass Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jiangsu Yikang Pharmaceutical Glass Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation